Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · IEX Real-Time Price · USD
6.33
-0.13 (-2.01%)
Apr 25, 2024, 4:00 PM EDT - Market closed
Larimar Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for LRMR stock have an average target of 18.5, with a low estimate of 10 and a high estimate of 25. The average target predicts an increase of 192.26% from the current stock price of 6.33.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LRMR stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $25 | Buy | Initiates | $25 | +294.94% | Apr 3, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $25 | Buy | Reiterates | $25 | +294.94% | Mar 15, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $25 | Buy | Reiterates | $25 | +294.94% | Mar 12, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $4.5 → $10 | Strong Buy | Maintains | $4.5 → $10 | +57.98% | Feb 13, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $17 → $25 | Buy | Maintains | $17 → $25 | +294.94% | Feb 13, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.26
from -0.84
EPS Next Year
-2.14
from -1.26
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 62.5M | 26.3M | 117.0M |
| Avg | n/a | n/a | 52.6M | 25.5M | 113.6M |
| Low | n/a | n/a | 42.8M | 24.5M | 109.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | -50.1% | 358.7% |
| Avg | - | - | - | -51.6% | 345.6% |
| Low | - | - | - | -53.5% | 328.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.23 | -1.96 | -1.70 |
| Avg | -1.26 | -2.14 | -2.38 |
| Low | -1.27 | -2.35 | -2.67 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.